Líneas de investigación

• Tromboembolismo pulmonar e Hipertensión pulmonar
• Neumopatías intersticiales
• Infección Covid
• Factores psicológicos y patología respiratoria.
• Bronquiectasias e infecciones respiratorias. 
• EPOC y terapia respiratoria
• Asma bronquial 

 

Grupos y Redes

• Integrados en el Instituto Biosanitario (Ibs) de Granada en el Grupo E-17: Investigación en Neumología: Terapia y Analítica Avanzada. ÁREA DE EPIDEMIOLOGÍA Y SALUD PÚBLICA. 
• Grupo CIBERES CB17/06/00030. Bernardino Alcázar Navarrete
• Grupo de investigación Covid multidisciplinar
• Grupo PAIDI: CTS261 PSICOFISIOLOGÍA CLÍNICA Y PROMOCIÓN DE LA SALUD. UNIVERSIDAD DE GRANADA
• Grupo PAIDI: Tecnologías de la información, comunicaciones e ingeniería aplicadas a la salud. Código TIC213

 

Últimas publicaciones

 

• PUBLICACIONES LIDERADAS EN LOS ULTIMOS 5 AÑOS (2020-2025)

 

• Número de publicaciones	73
  Publicaciones en revistas nacionales	20
  Publicaciones en revistas internacionales	53
  Publicaciones en Q1	42
  Publicaciones en Q2	21
  Publicaciones en primer decil (D1)	22
  Factor de impacto acumulado	597,16

   

   

• Rojo-Tolosa S, Sánchez-Martínez JA, Caballero-Vázquez A, Pineda-Lancheros LE, González-Gutiérrez MV, Pérez-Ramírez C, Jiménez-Morales A, Morales-García C. SingleNucleotide Polymorphisms as Biomarkers of Mepolizumab and Benralizumab Treatment Response in Severe Eosinophilic Asthma. Int J Mol Sci. 2024 Jul 26;25(15):8139. doi: 10.3390/ijms25158139. PMID: 39125709; PMCID: PMC11311889.
• Del Mar Sánchez Suárez M, Martín Roldan A, Rojo-Tolosa S, Jiménez-Morales A,Morales-García C. Factors influencing the real-world effectiveness of benralizumab in uncontrolled asthma. Sci Rep. 2025 Jul 1;15(1):21777. doi: 10.1038/s41598-025-07275-0. PMID: 40596465; PMCID: PMC12219857.
• Rojo-Tolosa S, Caballero-Vázquez A, Pineda-Lancheros LE, Sánchez-Martínez JA,González-Gutiérrez MV, Jiménez-Gálvez G, Jiménez-Morales A, Morales-García C. Drug survival of omalizumab in atopic asthma: Impact of clinical and genetic variables. Hum Vaccin Immunother. 2025 Dec;21(1):2488557. doi:10.1080/21645515.2025.2488557. Epub 2025 Apr 6. PMID: 40189906; PMCID:PMC12054927.
• Jiménez-Rodríguez BM, Gutiérrez-Fernández J, Ramos-Urbina EM, Romero-Ortiz AD, García-Flores PI, Santiago-Puertas MI, Martín-López MJ, López-Milena G, Fabregas R, Morales-García C. On the single and multiple associations of COVID-19 post-acute sequelae: 6-month prospective cohort study. Sci Rep. 2022 Mar 1;12(1):3402. doi: 10.1038/s41598-022-07433-8. PMID: 35233062; PMCID:PMC8888754.
• Triviño-Ibáñez EM, Jiménez-Rodríguez BM, Rudolphi-Solero T, García-Rivero EY,Rodríguez-Fernández A, Llamas-Elvira JM, Gómez-Río M, Morales-García C. [¹⁸F]FDG PET/CT in Short-Term Complications of COVID-19: Metabolic Markers of Persistent Inflammation and Impaired Respiratory Function. Diagnostics (Basel). 2022 Mar 29;12(4):835. doi: 10.3390/diagnostics12040835. PMID: 35453883; PMCID: PMC9025979.
• Rojo-Tolosa S, González-Gutiérrez MV, Sánchez-Martínez JA, Jiménez-Gálvez G, Pineda-Lancheros LE, Gálvez-Navas JM, Jiménez-Morales A, Pérez-Ramírez C, Morales-García C. Impact of Omalizumab in Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study. Pharmaceutics. 2023 Feb 4;15(2):523. doi: 10.3390/pharmaceutics15020523. PMID:36839845; PMCID: PMC9962091.
• Rojo-Tolosa S, González-Gutiérrez MV, Jiménez-Gálvez G, Sánchez-Martínez JA, Pineda-Lancheros LE, Gálvez-Navas JM, Jiménez-Morales A, Pérez-Ramírez C, Morales-García C. Impact of Anti-IL5 Therapies on Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study. Int J Mol Sci. 2023 Jan 19;24(3):2011. doi: 10.3390/ijms24032011. PMID: 36768331; PMCID: PMC9917054.
• Jiménez-Rodríguez BM, Triviño-Ibáñez EM, Gutiérrez-Fernández J, Romero-Ortiz AD, Ramos-Urbina EM, Morales-García C. Abnormal Alpha-1 Antitrypsin Levels and Other Risk Factors Associated with Lung Function Impairment at 6 and 12 Months after Hospitalization Due to COVID-19: A Cohort Study. Healthcare (Basel). 2022 Nov 22;10(12):2341. doi: 10.3390/healthcare10122341. PMID: 36553867; PMCID:PMC9777719.
• Pérez-Gisbert L, Morales-García C, Sánchez-Martínez JA, González-Gutiérrez MV, Valenza MC, Torres-Sánchez I. Severity Matters: How COVID-19 Severity Impacts Long-Term Effects on Symptoms, Physical Activity and Functionality-An Observational Study. Healthcare (Basel). 2025 Feb 6;13(3):333. doi: 10.3390/healthcare13030333. PMID: 39942522; PMCID: PMC11817242.
• Rojo-Tolosa S, Pineda-Lancheros LE, Fernández-Alonso A, Márquez-Pete N, Cura Y, Membrive-Jiménez C, Iglecias-Marangoni LM, Ramírez-Tortosa M, Gálvez-Navas JM, Pérez-Ramírez C, Morales-García C, Jiménez-Morales A. Vitamin D metabolism- related single nucleotide polymorphisms in Chronic Obstructive Pulmonary Disease risk. Front Endocrinol (Lausanne). 2024 Nov 8;15:1445712. doi: 10.3389/fendo.2024.1445712. PMID: 39583968; PMCID: PMC11581940.
• Rojo-Tolosa S, Sánchez-Martínez JA, Pineda-Lancheros LE, Gálvez-Navas JM, González-Gutiérrez MV, Jiménez-Gálvez G, Pérez-Ramírez C, Morales-García C, Jiménez-Morales A. Influence of Genetics on the Response to Omalizumab in Patients with Severe Uncontrolled Asthma with an Allergic Phenotype. Int J Mol Sci. 2023 Apr 10;24(8):7029. doi: 10.3390/ijms24087029. PMID: 37108192; PMCID: PMC10139019.
• Rojo-Tolosa S, Pineda-Lancheros LE, Gálvez-Navas JM, Sánchez-Martínez JA,González-Gutiérrez MV, Fernández-Alonso A, Morales-García C, Jiménez-Morales A, Pérez-Ramírez C. Association between Single Nucleotide Polymorphisms Related to Vitamin D Metabolism and the Risk of Developing Asthma. Nutrients. 2023 Feb 5;15(4):823. doi: 10.3390/nu15040823. PMID: 36839181; PMCID: PMC9964183.
• Roldán AM, Márquez Pete N, Sánchez Suárez MDM, Rojo Tolosa S, Jiménez Morales A. Clinical and Pharmacogenetic Factors Associated with Response to JAK Inhibitors in Patients with Rheumatoid Arthritis: A Real-World Study of JAK1, JAK2, and JAK3 Gene Variants. Pharmaceutics. 2026 Jul 11;18(7):846. doi: 10.3390/pharmaceutics18070846. PMID: 42514924; PMCID: PMC13415438.
• Rojo-Tolosa S, Márquez-Pete N, Gálvez-Navas JM, Pineda-Lancheros LE, Fernández-Alonso A, Membrive-Jiménez C, Ramírez-Tortosa MC, Pérez-Ramírez C, Jiménez-Morales A. Single Nucleotide Polymorphisms in the Vitamin D Metabolic Pathway and Their Relationship with High Blood Pressure Risk. Int J Mol Sci. 2023 Mar 22;24(6):5974. doi: 10.3390/ijms24065974. PMID: 36983047; PMCID: PMC10057633.
• Larrosa-García M, Pamplona IA, Tolosa SR, Morales AJ, Martínez MTS, Gallo MM, Colobran R, Vicente HG, Pena NM, Macías RPB, Ronsano JBM. Impact of FCGR2A and FCGR3A Gene Variants on the Response to Rituximab in Patients With Glomerular Diseases. Pharmacol Res Perspect. 2026 Jun;14(3):e70261. doi: 10.1002/prp2.70261. PMID: 42170767; PMCID: PMC13240126.
• Fernández A, Cura-Cuevas Y, Rojo-Tolosa S, Gálvez-Navas JM, González-Flores E, Pérez-Ramírez C, Jiménez-Morales A. Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Genes and Their Contribution to Breast Cancer Therapy. Pharmaceutics. 2026 May 22;18(6):633. doi: 10.3390/pharmaceutics18060633. PMID: 42357250; PMCID: PMC13306124.
• García-Río F, Alcázar-Navarrete B, Castillo-Villegas D, Cilloniz C, García- Ortega A, Leiro-Fernández V, Lojo-Rodriguez I, Padilla-Galo A, Quezada-Loaiza CA, Rodriguez-Portal JA, Sánchez-de-la-Torre M, Sibila O, Martínez-García MA. Biological Biomarkers in Respiratory Diseases. Arch Bronconeumol. 2022 Apr;58(4):323-333. English, Spanish. doi: 10.1016/j.arbres.2022.01.003. Epub 2022 Jan 17. PMID: 35312522.
• Turégano-Yedro M, Trillo-Calvo E, Navarro I Ros F, Maya-Viejo JD, González Villaescusa C, Echave Sustaeta JM, Doña E, Alcázar Navarrete B. Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment. Int J Chron Obstruct Pulmon Dis. 2023 Dec 4;18:2887-2893. doi: 10.2147/COPD.S431829. PMID:38059011; PMCID: PMC10697822.
• Alcázar-Navarrete B, Jamart L, Sánchez-Covisa J, Juárez M, Graefenhain R, Sicras-Mainar A. Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain. Chest. 2022 Nov;162(5):1017-1029. doi: 10.1016/j.chest.2022.06.033. Epub 2022 Jul 3. PMID: 35787391.
• Lopez-Campos JL, Alcázar Navarrete B. COPD Diagnosis in EPI-SCAN II. Arch Bronconeumol (Engl Ed). 2021 Mar;57(3):234. English, Spanish. Doi: 10.1016/j.arbres.2020.10.002. Oct 13. PMID: 33158642.
• Romero-Palacios PJ, Alcázar-Navarrete B. The perfect storm: when COPD meets bronchiectasis. ERJ Open Res. 2025 Mar 10;11(2):01023-2024. doi: 10.1183/23120541.01023-2024. PMID: 40071271; PMCID: PMC11895097.6:
• Alcázar-Navarrete B, Echave-Sustaeta JM. Microspirometers in the Follow-Up of COPD: Advantages and Disadvantages. Arch Bronconeumol (Engl Ed). 2021 Mar;57(3):160-161. English, Spanish. doi: 10.1016/j.arbres.2020.06.026.PMID: 32798006.
• Isea de la Viña J, Ramírez-Rodríguez G, Alcázar-Navarrete B. Segmentectomy in Lung Cancer as a New Standard of Treatment: Can Less Be More? Arch Bronconeumol. 2022 Oct;58(10):687-688. English, Spanish. doi: 10.1016/j.arbres.2022.05.015. Epub 2022 Jun 20. PMID: 35879121.
• Ramírez-Rodríguez G, Menéndez-Lobo A, Romero-Linares A, Bernabéu-Fernández de Liencres M, Romero-Palacios PJ, Alcázar-Navarrete B; “Spanish COPD mortality study group”. Chronic obstructive pulmonary disease mortality in Spain between 1999 and 2019. Med Clin (Barc). 2024 Jan 12;162(1):9-14. English, Spanish. Doi: 10.1016/j.medcli.2023.07.032. Epub 2023 Oct 7. PMID: 37813726.
• Singh D, Lobo AM, Higham A, Navarrete BA. Biological Therapy in COPD Management: Current Evidence, Challenges and Opportunities. Arch Bronconeumol. 2025 Jul 29:S0300-2896(25)00269-8. English, Spanish. Doi: 10.1016/j.arbres.2025.07.017. Epub ahead of print. PMID: 40835544.
• de Miguel Díez J, Figueira Gonçalves JM, Rodríguez García C, Amado Diago CA, Barrecheguren M, Alcázar Navarrete B. Delphi Consensus on the Management of COPD Exacerbation Syndrome in Inpatient and Outpatient Settings. Open Respir Arch. 2025 Jun 24;7(4):100458. doi: 10.1016/j.opresp.2025.100458. PMID: 40734954; PMCID: PMC12301748.
• Hammadi A, Hoyas-Sánchez C, Romero-Linares A, Álvarez-Muro L, Menéndez-Lobo A, Romeral-Navarro D, Jiménez-Antón A, Almansa-López A, Casares-Martin-Moreno L, Sánchez-Álvarez E, Romero-Palacios PJ, Alcázar-Navarrete B. All-Cause and Cardiovascular Mortality With Single Inhaler Triple Therapy Versus Double Therapies for COPD: A Systematic Review and Metanalysis. Arch Bronconeumol. 2025 Feb 21:S0300-2896(25)00062-6. English, Spanish. Doi: 10.1016/j.arbres.2025.02.004. Epub ahead of print. PMID: 40050216.
• Alcázar-Navarrete B, Díaz-Lopez JM, García-Flores P, Ortega-Antelo M, Aguilar-Cruz I, Ruiz-Rodríguez O, Santiago-Diaz P, Romero Palacios PJ. T2 Biomarkers as Predictors of Exacerbations of Chronic Obstructive Pulmonary Disease. Arch Bronconeumol. 2022 Aug;58(8):595-600. English, Spanish. doi:10.1016/j.arbres.2021.11.006. Epub 2021 Nov 27. PMID: 35312535.
• Alcázar-Martínez IM, Romero-Palacios PJ, Alcázar-Navarrete B. Mepolizumab for Eosinophilic COPD: What Matinee Adds to COPD Management? Open Respir Arch. 2025 Aug 5;7(3):100475. doi: 10.1016/j.opresp.2025.100475. PMID: 40949745; PMCID: PMC12424411.
• Romero Ortiz AD, Jiménez-Rodríguez BM, López-Ramírez C, López-Bauzá Á,Pérez-Morales M, Delgado-Torralbo JA, Villalba Moral C, Alcazar-Navarrete B. Antifibrotic treatment adherence, efficacy and outcomes for patients with idiopathic pulmonary fibrosis in Spain: a real-world evidence study. BMJ Open Respir Res. 2024 Apr 24;11(1):e001687. doi: 10.1136/bmjresp-2023-001687. PMID: 38663886; PMCID: PMC11043774.
• Alcázar-Navarrete B, García-Rio F, Sánchez G, Mariscal E, García A, Cuesta M, Uría E, Miravitlles M. Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain. Int J Chron Obstruct Pulmon Dis. 2021 Jul 21;16:2149-2161. doi: 10.2147/COPD.S310319. PMID: 34321874; PMCID: PMC8312318.
• Amtil-Ouahdi I, Vergara F, Rio C, González-Martínez C, Jahn A, Forteza- Genestra MA, Gayá A, Calvo J, Sala-Llinas E, Navarrete BA, Romero-Ortiz AD, Monjo M, Ramis JM, Ortega FG. EVs Biodistribution and Antifibrotic Impact in Aged Lung Fibrosis Model. Biofactors. 2025 May-Jun;51(3):e70021. Doi: 10.1002/biof.70021. Erratum in: Biofactors. 2025 Jul-Aug;51(4):e70034. Doi: 10.1002/biof.70034. PMID: 40359198.
• Calle Rubio M, Alcázar-Navarrete B, López-Campos JL, Miravitlles M, Soler-Cataluña JJ, Fuentes Ferrer ME, Rodríguez Hermosa JL. Characteristics and actions in high-risk COPD in unstable patients: The EPOCONSUL audit. PLoS One. 2025 Jul 18;20(7):e0327775. doi: 10.1371/journal.pone.0327775. PMID: 40679959;PMCID: PMC12273953.
• Sánchez-García MA, Alcázar-Navarrete B, Cortiñas-Saenz M, Cordero Tous N,Gálvez Mateos R. Multidimensional Analysis of Quality of Life in Patients with Chronic Non-Cancer Pain and Short- and Long-Term Intrathecal Analgesic Therapy. Healthcare (Basel). 2024 Sep 18;12(18):1870. doi: 10.3390/healthcare12181870. PMID: 39337211; PMCID: PMC11431655.
• Díaz-Miravalls J, Romero-Linares A, Jiménez-Gómez M, Catalinas-Muñoz E, De Granda-Orive JI, Caballero-Vázquez A, Romero-Palacios P, Alcázar-Navarrete B. Efficacy and Safety of Bronchoscopic Lung Volume Reduction With Endobronchial Valves: A Systematic Review and Meta-analysis. Open Respir Arch. 2025 May 17;7(3):100443. doi: 10.1016/j.opresp.2025.100443. PMID: 40530361; PMCID:PMC12173060.
• Romero-Linares A, Cárdenas-Cruz A, Pérez-Villares JM, Sánchez-Martínez JA, Fuentes-García P, Alcázar-Navarrete B. Inclusion of the Intermediate Respiratory Care Unit as a Detection Area for Controlled Donation After Circulatory Death: Results of a Pilot Project. Arch Bronconeumol. 2025 Jul 5:S0300-2896(25)00234-0. English, Spanish. doi: 10.1016/j.arbres.2025.07.004. Epub ahead of print. PMID:40946042.
•  Alcázar-Navarrete B, Figueira-Gonçalves JM, Corregidor-García C, Fitas E, Sánchez-Covisa J; ORESTES group. Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dehydrate in Spain: ORESTES Study. Adv Ther. 2025 Sep 22. doi: 10.1007/s12325-025-03361-x. Epub ahead of print. PMID: 40982160.
• Alcázar-Navarrete B, Bernabé Barrios MJ, Caballero Vázquez A, et al. SeparSEPAR (Sociedad Española de Neumologia y Cirugía Torácica) Clinical Protocol on Endoscopic Lung Volume Reduction for Severe Emphysema. Open Respir Arch. 2025;8(1):100529. Published 2025 Dec 3. doi:10.1016/j.opresp.2025.100529. (enlace externo)
• Alcázar-Navarrete B, Romero-Linares A, De la Torre Navas J, et al. Early acquisition of E-FAST ultrasound skills in medical students: an observational study comparing portable and conventional devices. BMC Med Educ. 2025;26(1):47. Published 2025 Dec 5. doi:10.1186/s12909-025-08396-w. (enlace externo)
• Figueira Gonçalves JM, de Miguel Díez J, Alcázar Navarrete B, et al. Delphi Consensus on the Management of Patients With Advanced COPD: COPD-Avanz Working Group. Open Respir Arch. 2025;7(2):100411. Published 2025 Feb 6. doi:10.1016/j.opresp.2025.100411.
• Gale CP, Hurst JR, Hawkins NM, ... Delphi investigators. Identification and management of cardiopulmonary risk in patients with chronic obstructive pulmonary disease: a multidisciplinary consensus and modified Delphi study. Eur J Prev Cardiol. 2025;32(15):1445-1460. doi:10.1093/eurjpc/zwaf119
• Calle Rubio M, Cataluña JJS, Miravitlles M, et al. Development and Validation of a Quantitative Score for the Criteria Clinical Control in Stable COPD Proposed in the Spanish COPD Guidelines (GesEPOC): Results of the EPOCONSUL Audit. J Clin Med. 2025;14(3):707. Published 2025 Jan 22. doi:10.3390/jcm14030707
• Singh D, Brightling CE, Rabe KF, ...course investigators. Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial. Lancet Respir Med. 2025;13(1):47-58. doi:10.1016/S2213-2600(24)00324-2
• Romero-Linares A, Álvarez-Muro L, Hammadi A, Hoyas-Sánchez C, Jiménez-Antón A, Almansa-López A, Casares-Martin-Moreno L, Sánchez-Álvarez E, Murillo-Rodríguez A, Gómez-Mora M, Gómez-Pontes Cabrera T, Romero-Palacios PJ, Alcázar-Navarrete B. Short term exacerbation risk and exhaled nitric oxide in COPD. Respir Med. 2025 Jul;243:108134. doi: 10.1016/j.rmed.2025.108134. Epub 2025 Apr 30. PMID: 40316031.
• Janson C, Wilkinson A, Hisinger-Mölkänen H, et al. How to move towards more sustainable asthma care in Europe: an expert opinion paper. Breathe (Sheff). 2025;21(2):240229. Published 2025 May 13. doi:10.1183/20734735.0229-2024
• Álvarez-Muro L, Collado-Jiménez M, Hoyas-Sánchez C, Jiménez-Antón A, Casares-Martín-Moreno L, Almansa-López A, Rojo-Tolosa S, López-Torres L, Jiménez-Rodríguez B, Romero-Ortiz AD, Romero-Palacios PJ, Alcázar-Navarrete B. Changing Mortality Patterns in Idiopathic Pulmonary Fibrosis in Spain: Sex-Specific and Regional Joinpoint Trends, 1999-2021. Arch Bronconeumol. 2026 Jul 4:S0300-2896(26)00251-6. English, Spanish. doi: 10.1016/j.arbres.2026.06.016. Epub ahead of print. PMID: 42469061.
• Díaz López JM, Guerrero Jiménez JM, Láinez Ramos-Bossini AJ, García Cerezo M, Ortega Sánchez FG, Alcázar Navarrete B. Novel biomarkers for lung cancer diagnosis in chronic obstructive pulmonary disease: a systematic review and metanalysis. Discov Oncol. 2026 Mar 21;17(1):1194. doi: 10.1007/s12672-026-04602-3. PMID: 41863663; PMCID: PMC13481974.
• Hoyas-Sánchez C, Romero-Palacios PJ, Alcazar Navarrete BGuidelines adherence: from quality indicator to prognostic relevanceThorax 2026;81:719-720.
• Cordero-Tous N, Salmerón-Martín M, Alcazar-Navarrete B, Cortiñas-Sáez M, Gálvez-Mateos R, Sánchez-García MA. Intrathecal Drug Delivery as a Rescue Strategy in Patients with Spinal Cord Stimulation: A Single-Center Case Series. J Clin Med. 2026 Jun 11;15(12):4518. doi: 10.3390/jcm15124518. PMID: 42355686; PMCID: PMC13301504.
• Alcázar-Navarrete B, Figueira-Gonçalves JM, Blanco Cid N, Bruguera Avila N, Bernabeu Mora R, Fuster Gomila A, Galera Martínez R, García Clemente MM, Granados G, Khadour Khadour H, Márquez-Martín E, Murga Arizabaleta I, Velasco Garrido JL, Corregidor-García C, Fitas E, Sánchez-Covisa J. Real-World Outcomes across Baseline Risk Profiles in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate in Spain: Insights from the ORESTES Study. Pulm Ther. 2026 Jun;12(2):667-689. doi: 10.1007/s41030-026-00366-x. Epub 2026 Jun 2. PMID: 42228247; PMCID: PMC13287286.
• Sadatsafavi M, Miravitlles M, Quint JK, Perugini V, Tavakoli H, Amegadzie JE, Alcazar Navarrete B; Respiratory Effectiveness Group (REG)-COPD working group. Development and validation of PRECISE-X model: predicting first severe exacerbation in COPD. Thorax. 2026 May 14;81(6):541-547. doi: 10.1136/thorax-2025-223770. PMID: 41476013; PMCID: PMC13217063.
• Figueira-Gonçalves JM, Alcázar-Navarrete B, de Miguel-Díez J. Triple Therapy in Routine Clinical Practice: Beyond Clinical Trials in COPD. Open Respir Arch. 2026 Feb 18;8(2):100599. doi: 10.1016/j.opresp.2026.100599. PMID: 41858384; PMCID: PMC12995886.
• Alcázar Navarrete B, Alonso Ortiz MB, Doña Díaz E, Echave-Sustaeta María-Tomé JM, Gargantilla Madera P, González Villaescusa C, Maya Viejo JD, Navarro Ros FM, Trillo Calvo E, Turegano-Yedro M, Martínez Ferreras A. Impact-Driven Strategies for Optimizing Inhaled Therapy Adherence in COPD: The OPTIMO Delphi Consensus. Open Respir Arch. 2026 Feb 3;8(2):100587. doi: 10.1016/j.opresp.2026.100587. PMID: 41767188; PMCID: PMC12936937.
• de Simón Gutiérrez R, Alcázar Navarrete B, Alonso Ortiz MB, Delgado Jiménez JF, Gómez Doblas JJ, Hurtado García R, López Caro JC, Méndez Bailón M, Núñez Villota J, Piñera Salmerón P, Pulido Herrero E, Rey Aldana D, Soler-Cataluña JJ, Trigueros Carrero JA, Zamorano Serrano MJ, de Miguel-Díez J. Integrated care for COPD and cardiovascular comorbidities: A multidisciplinary approach for the cardiopulmonary patient. Semergen. 2026 Mar;52(2):102678. doi: 10.1016/j.semerg.2025.102678. Epub 2026 Jan 19. PMID: 41558139.
• Alcázar-Navarrete B, Miravitlles M, Riesco JA, Soler-Cataluña JJ. Insights into the Follow-Up of Patients with COPD in Daily Practice: Results from a Spanish Delphi Consensus ("The SEGUIPOC Study”). Int J Chron Obstruct Pulmon Dis. 2026;21:610382
• Almansa-López A, Romero-Palacios PJ, Alcazar Navarrete B. When biomarkers disagree: interpreting FeNO and eosinophils across airway disease. Thorax. 2026 May 14;81(6):522-523. doi: 10.1136/thorax-2026-224810. PMID: 42055912; PMCID: PMC13217013.
• Soler-Cataluña JJ, Villagrasa M, Catalán P, Alcázar-Navarrete B, Calle Rubio M, Miravitlles M. Risk validation of a new quantitative score for clinical control of chronic obstructive pulmonary disease: The RADAR score. Arch Bronconeumol. 2026 Jan;62(1):28-34. English, Spanish. doi: 10.1016/j.arbres.2025.06.003. Epub 2025 Jun 16. PMID: 40592678.
• Ortega FG, Gómez GE, González-Martinez C, Valero T, Expósito-Hernández J, Puche I, Rodriguez-Martinez A, Serrano MJ, Lorente JA, Fernández-Baldo MA. A Novel, Quick, and Reliable Smartphone-Based Method for Serum PSA Quantification: Original Design of a Portable Microfluidic Immunosensor-Based System. Cancers (Basel). 2022 Sep 16;14(18):4483. doi: 10.3390/cancers14184483. PMID: 36139646; PMCID: PMC9496945.
• Miguel-Perez D, Ortega FG, Tejada RG, Martínez-Única A, Peterson CB, RussoA, Gunasekaran M, Cardona AF, Amezcua V, Lorente JA, Expósito Hernández J, Rolfo C, Serrano MJ. Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer. Biomark Res. 2023 Nov 15;11(1):98. doi: 10.1186/s40364-023-00544-y. PMID: 37968730; PMCID: PMC10652484.
• Regiart M, Fernández-Baldo MA, Navarrete BA, Morales García C, Gómez B, Tortella GR, Valero T, Ortega FG. Five years of advances in electrochemical analysis of protein biomarkers in lung cancer: a systematic review. Front Chem. 2024 May 3;12:1390050. doi: 10.3389/fchem.2024.1390050. PMID: 38764920; PMCID:PMC11099832.
• Emiliano Felici; Coral González-Martínez; Teresa Valero Griñán; Sheila Gato- ambrano; Sirley V. Pereira; Martín A. Fernández-Baldo; Francisco G. Ortega-Sanchez. Electrochemical immunoplatform for the quantification of epithelial extracellular vesicles applied to prostate cancer diagnosis. Talanta. 293 - 128130, pp. 128130. Elsevier, 01/10/2025. ISSN 0039-9140 DOI: 10.1016/j.talanta.2025.128130
• Serrano-Martínez JL, Caballero-Vázquez A, Núñez-Talavera M. Necrotizing tracheobronchial aspergillosis in an immunosuppressed patient. Med Intensiva (Engl Ed). 2023 Nov;47(11):680. doi: 10.1016/j.medine.2023.05.014. Epub 2023 Jun 17. PMID: 37336663.
• Chami-Peña S, Caballero-Vázquez A, Mebrive-Jiménez MJ, Gómez-Urquiza JL, Romero-Bejar JL, Caballero-Mateos AM, Cañadas-De la Fuente GA. Therapeutic Management in Patients with Chronic Obstructive Pulmonary Disease Who Are Overweight or Obese: A Systematic Review and Meta-Analysis. J Clin Med. 2025 Feb 13;14(4):1230. doi: 10.3390/jcm14041230. PMID: 40004760; PMCID: PMC11856468.
• Caballero-Vázquez A, Romero-Béjar JL, Albendín-García L, Suleiman-Martos N, Gómez-Urquiza JL, Cañadas GR, Cañadas-De la Fuente GA. Risk Factors for Short-Term Lung Cancer Survival. J Clin Med. 2021 Feb 1;10(3):519. doi: 10.3390/jcm10030519. PMID: 33535673; PMCID: PMC7867142.
• Granados-Bolivar ME, Quesada-Caballero M, Suleiman-Martos N, Romero-Béjar JL,Albendín-García L, Cañadas-De la Fuente GA, Caballero-Vázquez A. Evolution of Acute Respiratory Distress Syndrome in Emergency and Critical Care: Therapeutic Management before and during the Pandemic Situation. Medicina (Kaunas). 2022 May 28;58(6):726. doi: 10.3390/medicina58060726. PMID: 35743989; PMCID: PMC9229826.
• Suleiman-Martos N, Caballero-Vázquez A, Gómez-Urquiza JL, Albendín-García L, Romero-Béjar JL, Cañadas-De la Fuente GA. Prevalence and Risk Factors of Respiratory Syncytial Virus in Children under 5 Years of Age in the WHO European Region: A Systematic Review and Meta-Analysis. J Pers Med. 2021 May 15;11(5):416. doi: 10.3390/jpm11050416. PMID: 34063453; PMCID: PMC8155861.
• Fouz-Rosón N, Romero-Ortiz AD, Jiménez-Rodríguez BM, López-Bauzá Á, Rodríguez-Portal JA, Palacios-Hidalgo Z, Ferrer-Galván M, Guerrero-Zamora P, Morales MP, Expósito-Ruiz M. Infectious Exacerbations of Idiopathic Pulmonary Fibrosis. Arch Bronconeumol. 2022 Jul;58(7):566-568. English, Spanish. Doi: 10.1016/j.arbres.2021.05.025. Epub 2021 Jun 17. PMID: 35312599.
• Maher TM, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM, Kreuter M, Oldham JM, Richeldi L, Valenzuela C, Wijsenbeek MS, Clerisme-Beaty E, Coeck C, Gu H, Ritter I, Schlosser A, Stowasser S, Voss F, Weimann G, Zoz DF, Martinez FJ; FIBRONEER-ILD Trial Investigators. Nerandomilast in Patients with Progressive Pulmonary Fibrosis. N Engl J Med. 2025 Jun 12;392(22):2203-2214. doi: 10.1056/NEJMoa2503643. Epub 2025 May 19. PMID: 40388329.
• Richeldi L, Azuma A, Cottin V, Kreuter M, Maher TM, Martinez FJ, Oldham JM, Valenzuela C, Clerisme-Beaty E, Gordat M, Wachtlin D, Liu Y, Schlecker C, Stowasser S, Zoz DF, Wijsenbeek MS; FIBRONEER-IPF Trial Investigators. Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis. N Engl J Med. 2025 Jun 12;392(22):2193-2202. doi: 10.1056/NEJMoa2414108. Epub 2025 May 18. PMID: 40387033.
• Jackson DJ, Wechsler ME, Jackson DJ, Bernstein D, Korn S, Pfeffer PE, Chen R, Saito J, de Luíz Martinez G, Dymek L, Jacques L, Bird N, Schalkwijk S, Smith D, Howarth P, Pavord ID; SWIFT-1 and SWIFT-2 Investigators; SWIFT-1 Investigators; SWIFT-2 Investigators. Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype. N Engl J Med. 2024 Dec 19;391(24):2337-2349. doi: 10.1056/NEJMoa2406673. Epub 2024 Sep 9. PMID: 39248309.
• Navas-Ortega AC, Antonio Sánchez-Martínez J, García-Flores P, Morales-García C, Fabregas R. Data-driven modelling of IRCU patient flow during the COVID-19 pandemic. Comput Struct Biotechnol J. 2025 Oct 17;27:4657-4667. doi: 10.1016/j.csbj.2025.10.017. PMID: 41245894; PMCID: PMC12613035.
• Caballero-Vazquez A, Garcia-Cerezo M, Fernandez-Castro LR, Morales-Garcia C, Lainez Ramos-Bossini AJ, Vergara-Rubio F, Ortega-Sanchez FG, Sanchez-Maldonado JM. Liquid biopsy biomarkers for accurate detection of malignant pulmonary nodules: a meta-analytic approach. Discov Oncol. 2026 Jan 29;17(1):178. doi: 10.1007/s12672-025-03646-1. PMID: 41612093; PMCID: PMC12855667.
• Solano-Parada J, Sánchez-Martínez JA, Gómez-Hernández BC, Barriga M, García-Velasco P, Fenández A, Cornet-Gómez A, Albornoz AOCd, Fabregas R, Morales-García C. Exploring novel kinetics of automated H2O2 nebulization: a breakthrough in SARS-CoV-2 elimination. Microbiol Spectr. 2026 Apr 3;14(5):e0084225. doi: 10.1128/spectrum.00842-25. Epub ahead of print. PMID: 41930974; PMCID: PMC13141947.

   

   

 

PUBLICACIONES S. NEUMOLOGÍA 2021

• J. Trujillo-Santos, P. Beroiz, F. Moustafa, A. Alonso, E. Morejon, R. López-Reyes, I. Casado, JA. Porras, K. Flores, JJ. López-Núñez, M. Monreal. Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].. Thrombosis research. 2021 (doi:10.1016/j.thromres.2021.10.019 (enlace externo) PMID:34740456 (enlace externo))
• B. Alcázar-Navarrete, F. García-Rio, G. Sánchez, E. Mariscal, A. García, M. Cuesta, E. Uría, M. Miravitlles. Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain.. International journal of chronic obstructive pulmonary disease. 2021 16: pp. 2149 - 2161 (doi:10.2147/COPD.S310319 (enlace externo) PMID:34321874 (enlace externo))
• N. Suleiman-Martos, A. Caballero-Vázquez, JL. Gómez-Urquiza, L. Albendín-García, JL. Romero-Béjar, GA. Cañadas-De la Fuente. Prevalence and Risk Factors of Respiratory Syncytial Virus in Children under 5 Years of Age in the WHO European Region: A Systematic Review and Meta-Analysis.. Journal of personalized medicine. 2021 11(5) (doi:10.3390/jpm11050416 (enlace externo) PMID:34063453 (enlace externo))
• G. Bermudo, G. Suarez-Cuartin, P. Rivera-Ortega, JA. Rodriguez-Portal, J. Sauleda, B. Nuñez, D. Castillo, M. Aburto, K. Portillo, E. Balcells, D. Badenes-Bonet, C. Valenzuela, E. Fernandez-Fabrellas, T. González-Budiño, E. Cano, O. Acosta, V. Leiro-Fernández, A. Romero, L. Planas-Cerezales, A. Villar, A. Moreno, R. Laporta, V. Vicens-Zygmunt, J. Shull, T. Franquet, P. Luburich, M. Molina-Molina. Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity. Archivos de bronconeumologia. 2021 (doi:10.1016/j.arbres.2021.03.018 (enlace externo) PMID:33895005 (enlace externo))
• A. Caballero-Vázquez, JL. Romero-Béjar, L. Albendín-García, N. Suleiman-Martos, JL. Gómez-Urquiza, GR. Cañadas, GA. Cañadas-De la Fuente. Risk Factors for Short-Term Lung Cancer Survival.. Journal of clinical medicine. 2021 10(3) (doi:10.3390/jcm10030519 (enlace externo) PMID:33535673 (enlace externo))
• OM. Moreno-Arrones, A. Lobato-Berezo, A. Gomez-Zubiaur, S. Arias-Santiago, D. Saceda-Corralo, C. Bernardez-Guerra, R. Grimalt, P. Fernandez-Crehuet, J. Ferrando, R. Gil, A. Hermosa-Gelbard, R. Rodrigues-Barata, D. Fernandez-Nieto, S. Merlos-Navarro, S. Vañó-Galván. SARS-CoV-2-induced telogen effluvium: a multicentric study.. Journal of the European Academy of Dermatology and Venereology : JEADV. 2021 35(3): pp. e181 - e183 (doi:10.1111/jdv.17045 (enlace externo) PMID:33220124 (enlace externo))
• M. Barrecheguren, M. Torres-Duran, F. Casas-Maldonado, M. Miravitlles. Spanish Implementation of the New International Alpha-1 Anitrypsin Deficiency International Registry: The European Alpha-1 Research Collaboration (EARCO).. Archivos de bronconeumologia. 2021 57(2): pp. 81 - 82 (doi:10.1016/j.arbres.2020.02.003 (enlace externo) PMID:32197815 (enlace externo))
• J. Jiménez-Jáimez, R. Macías-Ruiz, F. Bermúdez-Jiménez, R. Rubini-Costa, J. Ramírez-Taboada, PIG. Flores, L. Gallo-Padilla, JDM. García, CM. García, SM. Suárez, CF. Molina, MÁ. López, L. Tercedor. Absence of relevant QT interval prolongation in not critically ill COVID-19 patients.. Scientific reports. 2020 10(1): pp. 21417 - 21417. FI: 3.998 Q1. (doi:10.1038/s41598-020-78360-9 (enlace externo) PMID:33293554 (enlace externo))
• J. Trujillo-Santos, P. Beroiz, F. Moustafa, A. Alonso, E. Morejon, R. López-Reyes, I. Casado, JA. Porras, K. Flores, JJ. López-Núñez, M. Monreal. Corrigendum to \"Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism\" [Thromb. Res. 193 (2020) 160-165].. Thrombosis research. 2020 196: pp. 641 - 641 (doi:10.1016/j.thromres.2020.10.001 (enlace externo) PMID:33066997 (enlace externo))
• I. Blanco, I. Diego, P. Bueno, S. Pérez-Holanda, F. Casas-Maldonado, M. Miravitlles. Prevalence of α-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review.. European respiratory review : an official journal of the European Respiratory Society. 2020 29(157) (doi:10.1183/16000617.0014-2020 (enlace externo) PMID:32699024 (enlace externo))
• J. Trujillo-Santos, P. Beroiz, F. Moustafa, A. Alonso, E. Morejon, R. López-Reyes, I. Casado, JA. Porras, K. Flores, JJ. López-Núñez, M. Monreal. Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism.. Thrombosis research. 2020 193: pp. 160 - 165 (doi:10.1016/j.thromres.2020.06.035 (enlace externo) PMID:32623185 (enlace externo))
• JM. Díaz López, A. Caballero Vázquez, JL. López Hidalgo, B. Márquez Lobo. EBUS-TBNA diagnosis of a granulomatous reaction to Surgicel in mediastinal adenopathy.. Archivos de bronconeumologia. 2020 56(7): pp. 460 - 461 (doi:10.1016/j.arbres.2019.12.027 (enlace externo) PMID:32044142 (enlace externo))
• A. Caballero Vázquez, P. Garcia Flores, A. Romero Ortiz, R. García Del Moral, B. Alcázar-Navarrete. Small cell lung cancer: Recent changes in clinical presentation and prognosis.. The clinical respiratory journal. 2020 14(3): pp. 222 - 227 (doi:10.1111/crj.13119 (enlace externo) PMID:31802620 (enlace externo))
• JM. Díaz López, B. Giran González, B. Alcázar-Navarrete. Personalized Medicine in Chronic Obstructive Pulmonary Disease: How Close Are We?. Archivos de bronconeumologia. 2020 56(7): pp. 420 - 421 (doi:10.1016/j.arbres.2019.09.002 (enlace externo) PMID:31722826 (enlace externo))

 

PUBLICACIONES S. NEUMOLOGÍA 2022

1: Agustí A, Alcázar B, Ancochea J, Casanova C, Celli B, Cosio B, Echave-Sustaeta JM, Fernandez Villar A, Garcia Rivero JL, González C, Izquierdo JL, Lopez-Campos JL, Marín Trigo JM, Martín Sánchez J, Miravitlles M, Molina J, Peces-Barba G, Roman M, Soler Cataluña JJ, Villar-Alvarez F. The ANTES program in COPD: First year. Arch Bronconeumol. 2022 Apr;58(4):291-294. English, Spanish. doi: 10.1016/j.arbres.2021.10.009. Epub 2021 Nov 19. PMID: 35312529. 

 

2: Moreno S, Alcázar B, Dueñas C, González Del Castillo J, Olalla J, Antela A. Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir. Drug Des Devel Ther. 2022 Mar 25;16:827-841. doi: 10.2147/DDDT.S356951. PMID: 35370401; PMCID: PMC8965332.

 

3: Miravitlles M, González-Torralba F, Represas-Represas C, Pomares X, Márquez-Martín E, González C, Amado C, Forné C, Alonso S, Alcázar B, Barrecheguren M, Jurado Mirete JM, Naval E. Pulmonologists' Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey. Int J Chron Obstruct Pulmon Dis. 2022 Jul 12;17:1577-1587. doi: 10.2147/COPD.S369118. PMID: 35855745; PMCID: PMC9288191.

 

4: Bustos Merlo A, Rosales Castillo A, López López L. Final inesperado. XV Reunión de EPOC: Casos Clínicos y Comunicaciones; 29 y 30 de septiembre de 2022. Grupo de EPOC de la Fundación Española de Medicina Interna. S&H Medical Science Service S.L. ISBN: 978-84-09-44209-6.

 

5: Jiménez-Rodríguez BM, Gutiérrez-Fernández J, Ramos-Urbina EM, Romero-Ortiz AD, García-Flores PI, Santiago-Puertas MI, Martín-López MJ, López-Milena G, Fabregas R, Morales-García C. On the single and multiple associations of COVID-19 post-acute sequelae: 6-month prospective cohort study. Sci Rep. 2022 Mar 1;12(1):3402. doi: 10.1038/s41598-022-07433-8. PMID: 35233062; PMCID: PMC8888754.

 

6: Romera-Vilchez M, Montero-Vilchez T, Herrero-Fernandez M, Rodriguez-Pozo JA, Jimenez-Galvez G, Morales-Garcia C, Buendia-Eisman A, Arias-Santiago S. Impact of Exposome Factors on Epidermal Barrier Function in Patients with Obstructive Sleep Apnea Syndrome. Int J Environ Res Public Health. 2022 Jan 7;19(2):659. doi: 10.3390/ijerph19020659. PMID: 35055481; PMCID: PMC8775463.

 

7: Triviño-Ibáñez EM, Jiménez-Rodríguez BM, Rudolphi-Solero T, García-Rivero EY, Rodríguez-Fernández A, Llamas-Elvira JM, Gómez-Río M, Morales-García C. [¹⁸F]FDG PET/CT in Short-Term Complications of COVID-19: Metabolic Markers of Persistent Inflammation and Impaired Respiratory Function. Diagnostics (Basel). 2022 Mar 29;12(4):835. doi: 10.3390/diagnostics12040835. PMID: 35453883; PMCID: PMC9025979.

 

8: Carneiro-Barrera A, Amaro-Gahete FJ, Guillén-Riquelme A, Jurado-Fasoli L, Sáez-Roca G, Martín-Carrasco C, Buela-Casal G, Ruiz JR. Effect of an Interdisciplinary Weight Loss and Lifestyle Intervention on Obstructive Sleep Apnea Severity: The INTERAPNEA Randomized Clinical Trial. JAMA Netw Open. 2022 Apr 1;5(4):e228212. doi: 10.1001/jamanetworkopen.2022.8212. PMID: 35452108; PMCID: PMC9034401.

 

9: Carneiro-Barrera A, Amaro-Gahete FJ, Jurado-Fasoli L, Sáez-Roca G, Martín- Carrasco C, Tinahones FJ, Ruiz JR. Effect of a Weight Loss and Lifestyle Intervention on Dietary Behavior in Men with Obstructive Sleep Apnea: The INTERAPNEA Trial. Nutrients. 2022 Jun 30;14(13):2731. doi: 10.3390/nu14132731. PMID: 35807913; PMCID: PMC9268365.

 

10: De la Rosa Carrillo D, Martínez-García MÁ, Barreiro E, Tabernero Huguet E, Costa Sola R, García-Clemente MM, Celorrio Jiménez N, Rodríguez Pons L, Calero Acuña C, Rodríguez Hermosa JL, Golpe R, Dacal Quintas R, Sánchez-Cuéllar S, Torres Arroyo I, Blanco Aparicio M, Almadana Pacheco V, Miravitlles M; Study group on the effectiveness of inhaled antibiotic treatment in COPD; Study group on the effectiveness of inhaled antibiotic treatment in COPD. Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study. Arch Bronconeumol. 2022 Jan;58(1):11-21. English, Spanish. doi: 10.1016/j.arbres.2021.03.009. Epub 2021 Mar 19. PMID: 33849721.

 

11: Navas-Bueno B, Casas-Maldonado F, Padilla-Galo A, González-Moya-Mondelo E, Arenas-Gordillo M, Bioque-Rivera JC, Jimeno-Galván R, Cano-Gómez MS, López- Campos JL, Merlos-Navarro S, Valido-Morales A, Vaquero-Barrios JM. High Adherence, Microbiological Control and Reduced Exacerbations in Patients With Non-Cystic Fibrosis Bronchiectasis Treated With Nebulised Colistin. A Prospective Observational Study. Arch Bronconeumol. 2022 Apr 27:S0300-2896(22)00320-9. English, Spanish. doi: 10.1016/j.arbres.2022.03.023. Epub ahead of print. PMID: 35618581.

 

12: Zozaya N, Abdalla F, Casado Moreno I, Crespo-Diz C, Ramírez Gallardo AM, Rueda Soriano J, Alcalá Galán M, Hidalgo-Vega Á. The economic burden of pulmonary arterial hypertension in Spain. BMC Pulm Med. 2022 Mar 26;22(1):105. doi: 10.1186/s12890-022-01906-2. PMID: 35346140; PMCID: PMC8962538.

 

13: COVIDSurg Collaborative; GlobalSurg Collaborative. Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study. Anaesthesia. 2021 Nov;76(11):1454-1464. doi: 10.1111/anae.15560. Epub 2021 Aug 9. PMID: 34371522.

 

14: COVIDSurg Collaborative; GlobalSurg Collaborative. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia. 2022 Jan;77(1):28-39. doi: 10.1111/anae.15563. Epub 2021 Aug 24. PMID: 34428858; PMCID: PMC8652887.

 

15: Betancourt-Vicencio S, Prieto-Aldape MR, Alvarez-Villaseñor AS, Fuentes- Orozco C, Cortes-Flores AO, Castillo-Cardiel G, Sánchez-Martínez JA, Reyes- Elizalde EA, González-Hernández PG, Zamora-Inzunza JG, Romero-Arredondo VA, Barbosa-Camacho JF, Brancaccio-Pérez IV, Guzmán-Ramírez BG, González-Ojeda A. Effects of Oral Pirfenidone on Colon Anastomosis Healing and Adhesion Formation in Rats. Eur Surg Res. 2022 Feb 23. doi: 10.1159/000523711. Epub ahead of print. PMID: 35196655.

 

16: Alcázar-Navarrete B, Díaz-Lopez JM, García-Flores P, Ortega-Antelo M, Aguilar-Cruz I, Ruiz-Rodríguez O, Santiago-Diaz P, Romero Palacios PJ. T2 Biomarkers as Predictors of Exacerbations of Chronic Obstructive Pulmonary Disease. Arch Bronconeumol. 2022 Aug;58(8):595-600. English, Spanish. doi: 10.1016/j.arbres.2021.11.006. Epub 2021 Nov 27. PMID: 35312535.

 

17: García-Río F, Alcázar-Navarrete B, Castillo-Villegas D, Cilloniz C, García- Ortega A, Leiro-Fernández V, Lojo-Rodriguez I, Padilla-Galo A, Quezada-Loaiza CA, Rodriguez-Portal JA, Sánchez-de-la-Torre M, Sibila O, Martínez-García MA. Biological Biomarkers in Respiratory Diseases. Arch Bronconeumol. 2022 Apr;58(4):323-333. English, Spanish. doi: 10.1016/j.arbres.2022.01.003. Epub 2022 Jan 17. PMID: 35312522.

 

18: Isea de la Viña J, Ramírez-Rodríguez G, Alcázar-Navarrete B. Segmentectomy in Lung Cancer as a New Standard of Treatment: Can Less Be More? Arch Bronconeumol. 2022 Oct;58(10):687-688. English, Spanish. doi: 10.1016/j.arbres.2022.05.015. Epub 2022 Jun 20. PMID: 35879121.

 

19: Alcázar-Navarrete B, Díaz-Lopez JM, García-Flores P, Ortega-Antelo M, Aguilar-Cruz I, Ruiz-Rodríguez O, Santiago-Diaz P, Romero Palacios PJ. T2 Biomarkers as Predictors of Exacerbations of Chronic Obstructive Pulmonary Disease. Arch Bronconeumol. 2022 Aug;58(8):595-600. English, Spanish. doi: 10.1016/j.arbres.2021.11.006. Epub 2021 Nov 27. PMID: 35312535.

 

20: Rubio MC, López-Campos JL, Alonso JLI, Pitarch DM, Pascual MI, Navarrete BA, Falcones MV, Inglés MJA, López CC, Martínez CJÁ, Ruiz FO, Golpe R, Gomila AF, Guardia SP, Miranda JAR, Peces-Barba G, García-Río F, Muñiz MÁM, Cosío BG. Consensus on the Management of the COPD Patient in the COVID-19 Setting: COPD Forum Working Group. Arch Bronconeumol. 2022 May 18:S0300-2896(22)00345-3. doi: 10.1016/j.arbres.2022.04.011. Epub ahead of print. PMID: 35697565; PMCID: PMC9116041.

 

21: Alcázar-Navarrete B, Jamart L, Sánchez-Covisa J, Juárez M, Graefenhain R, Sicras-Mainar A. Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain. Chest. 2022 Jul 3:S0012-3692(22)01212-0. doi: 10.1016/j.chest.2022.06.033. Epub ahead of print. PMID: 35787391.

 

22: Pérez Moyano S, Méngibar Vallejo P, Arranz Solana C. Recurrent hemoptysis as a result of a primary tracheobronchial amylodosis. Med Clin (Barc). 2021 Nov 26;157(10):503-504. English, Spanish. doi: 10.1016/j.medcli.2020.11.018. Epub 2021 Jan 7. PMID: 33422293.

 

23: Fouz-Rosón N, Romero-Ortiz AD, Jiménez-Rodríguez BM, López-Bauzá Á, Rodríguez-Portal JA, Palacios-Hidalgo Z, Ferrer-Galván M, Guerrero-Zamora P, Morales MP, Expósito-Ruiz M. Infectious Exacerbations of Idiopathic Pulmonary Fibrosis. Arch Bronconeumol. 2022 Jul;58(7):566-568. English, Spanish. doi: 10.1016/j.arbres.2021.05.025. Epub 2021 Jun 17. PMID: 35312599.

 

24: Cano-Jiménez E, Romero Ortiz AD, Villar A, Rodríguez-Nieto MJ, Ramon A, Armengol S. Clinical management and acute exacerbations in patients with idiopathic pulmonary fibrosis in Spain: results from the OASIS study. Respir Res. 2022 Sep 7;23(1):235. doi: 10.1186/s12931-022-02154-y. PMID: 36071483; PMCID: PMC9450456.

 

25: Granados-Bolivar ME, Quesada-Caballero M, Suleiman-Martos N, Romero-Béjar JL, Albendín-García L, Cañadas-De la Fuente GA, Caballero-Vázquez A. Evolution of Acute Respiratory Distress Syndrome in Emergency and Critical Care: Therapeutic Management before and during the Pandemic Situation. Medicina (Kaunas). 2022 May 28;58(6):726. doi: 10.3390/medicina58060726. PMID: 35743989; PMCID: PMC9229826.

 

26: Bouza E, Vargas F, Alcázar B, et al. Air pollution and health prevention: A document of reflection. Rev Esp Quimioter. 2022;35(4):307-332. doi:10.37201/req/171.2021